Dr. Jacob Churg (1910 Churg ( -2005 was born in Dolhinow, a Belarusian city that later became a part of Poland and in 1939 was ceded to Russia during the partition of Poland by Russia and Germany. Churg's father, Wolf, was a physician, and his mother, Gita, a dentist. Jacob recalled reading his father's medical books and pestering him with many questions. He graduated with a medical degree from the University of Wilno (Poland) in 1933 and started working at the Department of Internal Medicine. He realized that he was less confident dealing with patients than with "tissues." In 1936, at the same university, he began his studies in experimental pathology.
When he arrived in the United States, his uncle, Dr. Louis Chargin, chief physician at the skin clinic at Mount Sinai Hospital, New York, invited him to work as a dermatologist. After some attempts with that clinical practice, he decided to work in the bacteriological laboratory conducting research in the toxicity of various sulfa preparations.
In 1942, he joined the Mount Sinai Department of Pathology whose director was Dr. Paul Klemperer, one of the greatest pathologists of the early twentieth century, and also studied under Dr. Sadao Otani, the legendary surgical pathologist. This is where Churg began his studies of renal diseases with autopsy material, and subsequently Jacob Churg (1910 Churg ( -2005 Lotte Strauss (1913 Strauss ( -1985 c Sinai School of Medicine with the rank of professor. Among her honors was the appointment as Special Consultant in Perinatal Pathology to the National Institute of Health. Churg later had a patient at Barnert Memorial Hospital who presented with lymphadenopathy and peripheral eosinophilia, and had a history of asthma. Lymph node biopsy showed early granulomas and became one of the pioneers in the interpretation of kidney biopsies. He developed many new techniques to enhance the examination and interpretation of renal histology, including electron microscopy when it became available. His studies on diseases that were poorly understood at the time established the modern standards for the comprehension of many kidney diseases, including lupus nephritis, focal glomerulosclerosis, diabetes mellitus, hemolytic uremic syndrome, crescentic glomerulonephritis, and amyloidosis. In addition, he studied pulmonary and pleural diseases (concentrating on those that were asbestos-related, including mesothelioma and lung cancer), and was an authority on vascular diseases.
THE SYNDROME
He was at Mount Sinai Hospital most of his career, while also serving as Chief of Pathology at Barnert Memorial Hospital, a community hospital in New Jersey. After military service during World War II, he commenced his long friendship and collaboration with Lotte Strauss at Mount Sinai Hospital.
Dr. Lotte Strauss (1913 Strauss ( -1985 was born in Nuremberg, Germany. She began her medical studies in Germany, but was forced to complete them in Siena, Italy, in 1937, where she first demonstrated interest in laboratory medicine. She moved to the United States in 1938, working at Beth Israel Hospital, New York, as a research assistant in bacteriology. She became committed to pathology after studying with Dr. Sydney Farber , a well-known pediatric pathologist, at Children's Hospital in Boston. He is remembered for Farber's disease and particularly for studies in childhood leukemia, which led to effective chemotherapy. Boston's Sydney Farber Institute is named after him.
In 1941, Straus also came to Mount Sinai Hospital, where Klemperer encouraged her to concentrate on pediatric pathology. Subsequently, she became recognized as one of the most important founders of the specialty. She was a pioneer of perinatal pathology and helped establish the Society for Pediatric Pathology. Her special interests included studies on the ultrastructure of the placenta in various fetal diseases, intrauterine infections, and vascular diseases.
In 1953, a pediatric pathology service was established at Mount Sinai and she was its director for more than 30 years until her death. In 1966, she became one of the founding faculty at the Mount The autopsy findings dispel any doubt regarding the diagnosis. Probably at the time of their first description, Churg and Strauss could not establish the association between the syndrome and the high occurrence of thromboembolic events, as they also occur with others ANCA-related vasculitides We take this opportunity to not only remember the syndrome but also the researchers and scientists who first described it and contributed greatly to our medical knowledge. eosinophilic infiltration, previously unknown to Churg. Among the considerations at that time was Hodgkin lymphoma, but the lymph nodes regressed and the patient died of cerebral hemorrhage, proven, at autopsy, to be due to central nervous system vasculitis. In addition, other tissues showed granulomas and eosinophilia.
Concomitantly, Strauss had a similar case at Mount Sinai Hospital. Reviewing the literature together, they found similar cases previously reported. Identifying similar cases in the Mount Sinai Hospital archives and others reported in the literature, Churg and Strauss collected 13 cases. All of them presented with asthma, fever, hypereosinophilia, and, to varying degrees, symptoms of cardiac failure, renal damage, and peripheral neuropathy resulting from vascular insufficiency in various organs. The syndrome they described showed widespread inflammatory cell infiltration in the walls of vessels and in the extravascular collagen tissue, including necrosis with eosinophilic exudate, severe "fibrinoid" necrosis, and proliferating granulomas comprised of epithelioid and giant cells. They designated this change, and the accompanying syndrome, as "allergic granulomatosis," suggesting that the granulomas indicated a variant of polyarteritis nodosa.
Three years later, in 1954, Churg and Gabriel C Godman, a pathologist at Columbia University, concluded that Churg-Strauss syndrome, Wegener granulomatosis, and microscopic polyangiitis were related types of vasculitis distinct from classic polyarteritis nodosa. All three typically affected small arteries, arterioles, capillaries, venules and veins, and might be associated with glomerulonephritis. This conclusion has greatly been strengthened by the observation that all three typically do not show a deposition of immunoglobulins in tissue (hence are labeled pauci-immune) and usually typically demonstrates circulating anti-neutrophil cytoplasmic antibodies (ANCA). Tissue samples are no longer required for diagnosis. Indeed, although eosinophilia is almost always seen, it is thought that the classic features of vasculitis and granulomatous inflammation are seen in only a minority of cases. Early cases may have rhinitis and asthma, with tissue eosinophilia, prior to the development of vasculitis. The cases without vasculitis are often highly responsive to steroid therapy, whereas more advanced cases may require cytotoxic and/or immunosuppressive treatment.
In this issue, a Churg-Strauss syndrome case is presented, which closely follows the clinical description by Dr. Jacob Churg and Dr. Lotte Strauss.
